Related references
Note: Only part of the references are listed.QKI impairs self-renewal and tumorigenicity of oral cancer cells via repression of SOX2
Wei Lu et al.
CANCER BIOLOGY & THERAPY (2014)
let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis
Wei Kang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Transcript Stabilization by the RNA-Binding Protein HuR Is Regulated by Cellular Retinoic Acid-Binding Protein 2
Amanda C. Vreeland et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy
Sara De Dosso et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Polymorphisms of Survivin and Its Protein Expression Are Associated with Colorectal Cancer Susceptibility in Chinese Population
Xia-Bin Li et al.
DNA AND CELL BIOLOGY (2013)
DNA Repair Gene XRCC1 Polymorphisms, Smoking, and Bladder Cancer Risk: A Meta-Analysis
Shan Li et al.
PLOS ONE (2013)
Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and colorectal cancer risk
Dong Mao et al.
TUMOR BIOLOGY (2013)
Systematic Meta-Analyses and Field Synopsis of Genetic Association Studies in Colorectal Cancer
Evropi Theodoratou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Potentially functional polymorphisms in DNA repair genes and non-small-cell lung cancer survival: A pathway-based analysis
Jing Dong et al.
MOLECULAR CARCINOGENESIS (2012)
Polymorphisms in ERCC1 and XPF Genes and Risk of Gastric Cancer in an Eastern Chinese Population
Jing He et al.
PLOS ONE (2012)
Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy
Li Yan et al.
PHARMACOGENOMICS (2012)
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
B. Besse et al.
ANNALS OF ONCOLOGY (2011)
ERCC1 (excision repair cross-complementation group 1) expression as a predictor for response of neoadjuvant chemotherapy for FIGO stage 2B uterine cervix cancer
Jong-Sup Park et al.
GYNECOLOGIC ONCOLOGY (2011)
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapy
Elisa Giovannetti et al.
PHARMACOGENOMICS (2011)
BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin
Hyun Jeong Shim et al.
CANCER SCIENCE (2010)
The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma
Xiao-Dong Cheng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients
Xinchen Sun et al.
LUNG CANCER (2009)
MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell - Introducing microRNA pharmacogenomics
Prasun J. Mishra et al.
CELL CYCLE (2008)
Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer
K. D. Steffensen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Multiple genetic and epigenetic interacting mechanisms' contribute to clonally selection of drug-resistant tumors: Current views and new therapeutic prospective
A Roberti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Human DNA repair genes, 2005
RD Wood et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
XRCC1 co-localizes and physically interacts with PCNA
JS Fan et al.
NUCLEIC ACIDS RESEARCH (2004)
Mechanisms of gene silencing by double-stranded RNA
G Meister et al.
NATURE (2004)
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer
D Isla et al.
ANNALS OF ONCOLOGY (2004)
Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy
JS Ryu et al.
LUNG CANCER (2004)
From genotype to phenotype:: correlating XRCC1 polymorphisms with mutagen sensitivity
YF Wang et al.
DNA REPAIR (2003)
The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif
JH Enzlin et al.
EMBO JOURNAL (2002)
ERCC1: A comparative genomic perspective
MD Wilson et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2001)
Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review
M Berwick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
